Literature DB >> 2385230

Glycoprotein nature of the A2-adenosine receptor binding subunit.

W W Barrington1, K A Jacobson, G L Stiles.   

Abstract

Mammalian A2-adenosine receptor binding subunits (A2AR) can be visualized by covalent labeling with the photoaffinity crosslinking ligand 125I-2-[4-[2-[2-[(4-aminophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl]ethylamino-5'-N-ethylcarboxamidoad enosine or directly with the azide derivative described in this paper. The protein comprising the A2-adenosine receptor binding subunit migrates with a Mr of 45,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In this study, the glycoproteins representing the radiolabeled A1- and A2-adenosine receptor binding subunit from bovine brain were compared by partial peptide maps and following treatment with exo- and endoglycosidases. Peptide maps using two separate proteases reveal that the A1- and A2-adenosine receptor binding subunits share no common peptide fragments by two-dimensional gel electrophoresis. Endoglycosidase F treatment of labeled A2AR results in a single labeled peptide of Mr 38,000 without intermediate peptides, suggesting a single N-linked carbohydrate chain. The labeled A2AR demonstrates a sensitivity to neuraminidase, as evidenced by an increased mobility on gel electrophoresis, suggesting the receptors contain a glycan component containing terminal sialic acid. Treatment of the labeled A2AR with alpha-mannosidase reveals two distinct populations of A2ARs, one of which is sensitive and the other resistant to the enzyme. The nonadditivity of sequential treatments with the two exoglycosidases suggests, a heterogeneous population of A2AR containing either complex- or high mannose-type carbohydrate chains. These data suggest the A2AR is a Mr 45,000 glycoprotein with a single carbohydrate chain of either the complex or high mannose type. In addition, the A1- and A2ARs are distinct glycoproteins, as evidenced by their differing molecular weights (before and after deglycosylation) and distinct peptide maps.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2385230      PMCID: PMC3454504     

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Demonstration of distinct agonist and antagonist conformations of the A1 adenosine receptor.

Authors:  W W Barrington; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

3.  125I-labeled p-azidobenzylcarazolol, a photoaffinity label for the beta-adrenergic receptor. Characterization of the ligand and photoaffinity labeling of beta 1- and beta 2-adrenergic receptors.

Authors:  T N Lavin; P Nambi; S L Heald; P W Jeffs; R J Lefkowitz; M G Caron
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

4.  Photoaffinity labelling of mammalian beta-adrenergic receptors: metal-dependent proteolysis explains apparent heterogeneity.

Authors:  J L Benovic; G L Stiles; R J Lefkowitz; M G Caron
Journal:  Biochem Biophys Res Commun       Date:  1983-01-27       Impact factor: 3.575

5.  Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.

Authors:  A De Lean; A A Hancock; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

6.  Characterization of the A1 adenosine receptor-adenylate cyclase system of cerebral cortex using an agonist photoaffinity ligand.

Authors:  G L Stiles; D T Daly; R A Olsson
Journal:  J Neurochem       Date:  1986-10       Impact factor: 5.372

7.  Peptide mapping of heterogeneous protein samples.

Authors:  C Bordier; A Crettol-Järvinen
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

8.  Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking.

Authors:  W W Barrington; K A Jacobson; A J Hutchison; M Williams; G L Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Mammalian beta-adrenergic receptors. Distinct glycoprotein populations containing high mannose or complex type carbohydrate chains.

Authors:  G L Stiles; J L Benovic; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

10.  Mammalian beta-adrenergic receptors. Structural differences in beta 1 and beta 2 subtypes revealed by peptide maps.

Authors:  G L Stiles; R H Strasser; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

View more
  14 in total

1.  Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations.

Authors:  T M Palmer; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1992-09       Impact factor: 4.436

2.  Desensitization of the canine A2a adenosine receptor: delineation of multiple processes.

Authors:  T M Palmer; T W Gettys; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1994-06       Impact factor: 4.436

3.  Molecular Characterization of A(1) and A(2a) Adenosine Receptors.

Authors:  Kenneth A Jacobson; Philip J M van Galen; Xiao-Duo Ji; Vickram Ramkumar; Mark E Olah; Gary L Stiles
Journal:  Drug Dev Res       Date:  2004-10-05       Impact factor: 4.360

4.  The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.

Authors:  C Nanoff; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

5.  A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.

Authors:  I Hide; W L Padgett; K A Jacobson; J W Daly
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

6.  Characterization of adenosine receptor in its native environment: insights from molecular dynamics simulations of palmitoylated/glycosylated, membrane-integrated human A(2B) adenosine receptor.

Authors:  Mahboubeh Mansourian; Armin Madadkar-Sobhani; Karim Mahnam; Afshin Fassihi; Lotfollah Saghaie
Journal:  J Mol Model       Date:  2012-05-09       Impact factor: 1.810

7.  Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.

Authors:  X D Ji; G L Stiles; P J van Galen; K A Jacobson
Journal:  J Recept Res       Date:  1992

Review 8.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

Review 9.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

10.  The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor.

Authors:  F Libert; S N Schiffmann; A Lefort; M Parmentier; C Gérard; J E Dumont; J J Vanderhaeghen; G Vassart
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.